| RS1085307946 |
FBN1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307947 |
KMT2A
|
Health Risk |
Likely pathogenic |
— |
| RS1085307950 |
PHEX
|
Health Risk |
Likely pathogenic |
— |
| RS1085307951 |
ADAR
|
Health Risk |
Likely pathogenic |
— |
| RS1085307952 |
ASL
|
Health Risk |
Conflicting classifications of pathogenicity |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1085307953 |
ATP1A2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307954 |
SHANK3
|
Health Risk |
Likely pathogenic |
— |
| RS1085307956 |
ASNS
|
Health Risk |
Likely pathogenic |
— |
| RS1085307957 |
VPS13B
|
Health Risk |
Likely pathogenic |
— |
| RS1085307958 |
BRAT1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, Neonatal-onset encephalopathy with rigidity and seizures |
| RS1085307960 |
ATP2A2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307961 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1085307962 |
AR
|
Health Risk |
Likely pathogenic |
— |
| RS1085307963 |
SLC19A3
|
Health Risk |
Likely pathogenic |
— |
| RS1085307964 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1085307965 |
KCNQ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS1085307966 |
FOXG1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307967 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1085307968 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 19, Cone-rod dystrophy 3 |
| RS1085307969 |
AARS2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307970 |
DARS2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307971 |
MEN1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1085307972 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS1085307973 |
COL9A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Epiphyseal dysplasia, multiple |
| RS1085307974 |
TUFM
|
Health Risk |
Likely pathogenic |
— |
| RS1085307976 |
POLG
|
Health Risk |
Likely pathogenic |
— |
| RS1085307977 |
MBTPS2
|
Health Risk |
Likely pathogenic |
— |
| RS1085307978 |
MYBPC3
|
Health Risk |
Likely pathogenic |
— |
| RS1085307982 |
COL4A1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307983 |
COL4A2
|
Health Risk |
Pathogenic |
— |
| RS1085307984 |
CASR
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1085307985 |
POMT2
|
Health Risk |
Pathogenic |
— |
| RS1085307987 |
SYNJ1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 53 |
| RS1085307988 |
ALOX12B
|
Health Risk |
Likely pathogenic |
— |
| RS1085307989 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal dominant form |
| RS1085307990 |
AIFM1
|
Health Risk |
Likely pathogenic |
— |
| RS1085307991 |
DDC
|
Health Risk |
Likely pathogenic |
— |
| RS1085307992 |
ATP1A3
|
Health Risk |
Likely pathogenic |
— |
| RS1085307993 |
GABRB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy 92, Developmental and epileptic encephalopathy 92 |
| RS1085307994 |
LAMB3
|
Health Risk |
Likely pathogenic |
— |
| RS1085307995 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS1085307996 |
KCNQ3
|
Health Risk |
Likely pathogenic |
— |
| RS1085307997 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1085307998 |
PEX5
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS1085307999 |
SCN8A
|
Health Risk |
Likely pathogenic |
Autism, Seizure |
| RS1085308000 |
CHD2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1085308001 |
TGM1
|
Health Risk |
Likely pathogenic |
— |
| RS1085308002 |
MMUT
|
Health Risk |
Pathogenic |
Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency, Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency |
| RS1085308003 |
FBP1
|
Health Risk |
Pathogenic |
— |
| RS1085308004 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1085308005 |
TUBA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Tubulinopathy |
| RS1085308006 |
IDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-II |
| RS1085308007 |
FLVCR1
|
Health Risk |
Likely pathogenic |
— |
| RS1085308008 |
RYR2
|
Health Risk |
Likely pathogenic |
— |
| RS1085308009 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1085308010 |
ITPR1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1085308012 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1085308013 |
SCN8A
|
Health Risk |
Likely pathogenic |
— |
| RS1085308014 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Alpha-actinopathy |
| RS1085308015 |
FUS
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 6, Tremor |
| RS1085308016 |
ARSA
|
Health Risk |
Likely pathogenic |
Metachromatic leukodystrophy, Metachromatic leukodystrophy |
| RS1085308017 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Junctional epidermolysis bullosa gravis of Herlitz |
| RS1085308019 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS1085308020 |
KCNA1
|
Health Risk |
Likely pathogenic |
Episodic ataxia type 1, Episodic ataxia type 1 |
| RS1085308021 |
PYGM
|
Health Risk |
Likely pathogenic |
— |
| RS1085308022 |
STXBP1
|
Health Risk |
Likely pathogenic |
— |
| RS1085308023 |
GABRB3
|
Health Risk |
Likely pathogenic |
— |
| RS1085308025 |
MYH7
|
Health Risk |
Likely pathogenic |
— |
| RS1085308026 |
TUBB3
|
Health Risk |
Likely pathogenic |
— |
| RS1085308027 |
ADCY5
|
Health Risk |
Likely pathogenic |
— |
| RS1085308028 |
SATB2
|
Health Risk |
Likely pathogenic |
SATB2-related disorder, SATB2-related disorder |
| RS1085308029 |
NTRK2
|
Health Risk |
Pathogenic |
Obesity, hyperphagia |
| RS1085308030 |
NPR2
|
Health Risk |
Likely pathogenic |
— |
| RS1085308031 |
WNT10A
|
Health Risk |
Likely pathogenic |
Odonto-onycho-dermal dysplasia, Schöpf-Schulz-Passarge syndrome |
| RS1085308032 |
ABCA12
|
Health Risk |
Likely pathogenic |
— |
| RS1085308033 |
PRUNE1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with microcephaly, hypotonia |
| RS1085308034 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1085308035 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1085308037 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1085308038 |
BRCA2
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1085308039 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1085308041 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1085308042 |
PTEN
|
Health Risk |
Pathogenic/Likely pathogenic |
PTEN hamartoma tumor syndrome, Cowden syndrome |
| RS1085308043 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1085308044 |
PTEN
|
Health Risk |
Likely pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1085308045 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1085308046 |
PTEN
|
Health Risk |
Likely pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1085308048 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1085308049 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Cowden syndrome 1 |
| RS1085308050 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1085308051 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, Macrocephaly-autism syndrome |
| RS1085308052 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1085308053 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1085308054 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1085308055 |
PTEN
|
Health Risk |
Pathogenic |
PTEN hamartoma tumor syndrome, PTEN hamartoma tumor syndrome |
| RS1085308056 |
PTEN
|
Health Risk |
Likely pathogenic |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1085308057 |
MSH2
|
Health Risk |
Likely pathogenic |
Lynch syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1085308062 |
EPG5
|
Health Risk |
Pathogenic |
Vici syndrome, Vici syndrome |
| RS10870182 |
INPP5E
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Joubert syndrome 1 |
| RS10877012 |
CYP27B1
|
Health Risk |
Likely risk allele |
Vitamin D-dependent rickets, type 1A |